IP Library Granted Patent US 8,512,592
Granted Patent B2
US 8,512,592 · App. 13/552,878 · Granted Aug 20, 2013

Heat-dissipating compositions comprising estolide compounds

Inventors: Jeremy Forest (Tustin, CA); Jakob Bredsguard (Irvine, CA); Travis Thompson (Anaheim, CA)
Assignee: Biosynthetic Technologies, LLC
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,512,592
App. No.
13/552,878
Granted
Aug 20, 2013
Kind
B2
Abstract

Provided herein are dielectric fluids comprising at least one estolide compound of formula: in which n is an integer equal to or greater than 0; m is an integer equal to or greater than 1; R 1 , independently for each occurrence, is selected from optionally substituted alkyl that is saturated or unsaturated, and branched or unbranched; R 2 is selected from hydrogen and optionally substituted alkyl that is saturated or unsaturated, and branched or unbranched; and R 3 and R 4 , independently for each occurrence, are selected from optionally substituted alkyl that is saturated or unsaturated, and branched or unbranched. Also provided herein are uses of dielectric fluids and electrical devices such as transformers that comprise a dielectric fluid comprising at least one estolide compound.

Claims (43)

1. A method of dissipating heat away from a device, comprising contacting at least a portion of the device with a composition having an EN selected from an integer or fraction of an integer that is equal to or less than 1.5, wherein the EN is the average number of estolide linkages in compounds according to Formula I, and wherein the composition comprises at least one estolide compound of Formula I:

wherein

x is, independently for each occurrence, an integer selected from 0 to 20;

y is, independently for each occurrence, an integer selected from 0 to 20;

n is an integer equal to or greater than 0;

R 1 is an optionally substituted alkyl that is saturated or unsaturated, and branched or unbranched; and

R 2 is selected from hydrogen and optionally substituted alkyl that is saturated or unsaturated, and branched or unbranched,

wherein each fatty acid chain residue of said at least one estolide compound is independently optionally substituted, and

wherein said composition has a total acid number equal to or less than 0.1 mg KOH/g.

2. The method according to claim 1 , wherein

x is, independently for each occurrence, an integer selected from 1 to 10;

y is, independently for each occurrence, an integer selected from 1 to 10;

n is an integer selected from 0 to 8;

R 1 is an optionally substituted C 1 to C 22 alkyl that is saturated or unsaturated, and branched or unbranched; and

R 2 is an optionally substituted C 1 to C 22 alkyl that is saturated or unsaturated, and branched or unbranched,

wherein each fatty acid chain residue is unsubstituted.

3. The method according to claim 2 , wherein

x+y is, independently for each fatty acid chain residue, an integer selected from 13 to 15; and

n is an integer selected from 0 to 6.

4. The method according to claim 3 , wherein x is, independently for each occurrence, an integer selected from 7 and 8.

5. The method according to claim 3 , wherein y is, independently for each occurrence, an integer selected from 7 and 8.

6. The method according to claim 3 , wherein x+y is 15 for at least one fatty acid chain residue.

7. The method according to claim 1 , wherein R 2 is an unsubstituted alkyl that is saturated or unsaturated, and branched or unbranched.

8. The method according to claim 1 , wherein R 2 is a branched or unbranched C 1 to C 20 alkyl that is saturated or unsaturated.

9. The method according to claim 8 , wherein R 2 is selected from methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, nonyl, decanyl, undecanyl, dodecanyl, tridecanyl, tetradecanyl, pentadecanyl, hexadecanyl, heptadecanyl, octadecanyl, nonadecanyl, and icosanyl, which are saturated or unsaturated and branched or unbranched.

10. The method according to claim 1 , wherein R 2 is selected from C 6 to C 12 alkyl.

11. The method according to claim 1 , wherein R 1 is a branched or unbranched C 1 to C 20 alkyl that is saturated or unsaturated.

12. The method according to claim 11 , wherein R 1 is selected from methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, nonyl, decanyl, undecanyl, dodecanyl, tridecanyl, tetradecanyl, pentadecanyl, hexadecanyl, heptadecanyl, octadecanyl, nonadecanyl, and icosanyl, which are saturated or unsaturated and branched or unbranched.

13. The method according to claim 1 , wherein R 1 is selected from unsubstituted C 7 to C 17 alkyl that is unbranched and saturated or unsaturated.

14. The method according to claim 13 , wherein R 1 is saturated.

15. The method according to claim 1 , wherein said composition has a kinematic viscosity equal to or less than 45 cSt when measured at 40° C.

16. The method according to claim 15 , wherein said composition has a pour point equal to or lower than −25° C.

17. The method according to claim 1 , wherein said composition further comprises at least one additive selected from one or more of an antioxidant, antimicrobial agent, a cold flow modifier, a pour point modifier, a metal chelating agent, or a metal deactivator.

18. The method according to claim 1 , wherein said composition has a fire point of greater than or equal to 300° C.

19. The method according to claim 1 , wherein said composition has a flash point of greater than or equal to 275° C.

20. The method according to claim 1 , wherein said composition has an electrical conductivity of less than or equal to 5 pS/M at 25° C.

21. The method according to claim 1 , wherein said composition has a color of less than or equal to 1 when measured according to ASTM Method D1500.

22. The method according to claim 1 , wherein said composition has a dielectric breakdown voltage under impulse conditions (25° C., needle negative to sphere grounded, 1 in.) of greater than or equal to 130 kV.

23. The method according to claim 17 , wherein the at least one additive comprises an antioxidant selected from BHT, BHA, TBHQ, DBPC, THBP, an alkylated diphenylamine, vitamin E, and ascorbyl palmitate.

24. The method according to claim 1 , wherein the device comprises at least one transformer.

25. The method according to claim 24 , wherein said at least one transformer comprises a housing and a core/coil assembly, wherein the core/coil assembly is positioned in the housing and wherein the composition surrounds at least a portion of the core/coil assembly.

26. The method according to claim 1 , wherein said device comprises a fluid-filled transmission cable.

27. The method according to claim 1 , wherein said composition further comprises at least one additive selected from one or more of a polyalphaolefin, a synthetic ester, a polyalkylene glycol, a mineral oil, a vegetable oil, an animal-based oil, a monoglyceride, a diglyceride, a triglyceride, or a fatty-acid ester.

Assignments (8)
ASSIGNMENT OF SECURITY INTEREST Recorded Mar 23, 2018
From: BP TECHNOLOGY VENTURES INC.
To: BIOSYN HOLDINGS, LLC
Reel/Frame 045688/0600 →
ASSIGNMENT OF SECURITY INTEREST Recorded Mar 23, 2018
From: EVONIK CORPORATION
To: BIOSYN HOLDINGS, LLC
Reel/Frame 045860/0547 →
ASSIGNMENT OF SECURITY INTEREST Recorded Mar 23, 2018
From: EVONIK OIL ADDITIVES USA, INC.
To: BIOSYN HOLDINGS, LLC
Reel/Frame 045684/0293 →
RELEASE OF SECURITY INTEREST Recorded Feb 13, 2018
From: SILICON VALLEY BANK
To: BIOSYNTHETIC TECHNOLOGIES, LLC
Reel/Frame 044916/0936 →
SECURITY INTEREST Recorded Jan 30, 2018
From: BIOSYNTHETIC TECHNOLOGIES, LLC
To: BP TECHNOLOGY VENTURES INC.
Reel/Frame 045196/0587 →
SECURITY INTEREST Recorded Mar 18, 2016
From: BIOSYNTHETIC TECHNOLOGIES, LLC
To: EVONIK OIL ADDITIVES USA, INC.
Reel/Frame 038146/0859 →
SECURITY INTEREST Recorded Nov 30, 2015
From: BIOSYNTHETIC TECHNOLOGIES, LLC
To: EVONIK CORPORATION
Reel/Frame 037162/0364 →
SECURITY INTEREST Recorded Dec 20, 2014
From: BIOSYNTHETIC TECHNOLOGIES, LLC
To: SILICON VALLEY BANK
Reel/Frame 034562/0322 →
Continuity (4)
Continuation 13407402 · Feb 28, 2012
Provisional Application 61548613 · Oct 18, 2011
Provisional Application 61498499 · Jun 17, 2011
Related Publication 20130015415A1 · Jan 17, 2013